The global amyloidosis treatment market is poised for strong growth as healthcare systems increasingly prioritize rare disease management, precision medicine, and advanced therapeutic interventions. Valued at USD 6.2 billion in 2025, the market is projected to reach USD 12.9 billion by 2035, growing at a 7.5% CAGR during the forecast period.
Growth is increasingly driven by therapeutic...
SPARK Website
عربي